Do you typically adjust or hold immunosuppression in a well-controlled RA patient who is being treated for Mycobacterium avium-intracellulare (MAI)?

Topics: Rheumatology • Rheumatoid Arthritis • General Rheumatology • Infectious Disease • Immunosuppression • Non-Tubercular Mycobacteria

Answer from: at Academic Institution

It depends on the RA activity and shared decision-making with the patient. A lot of these patients are at risk of MAI infection due to their underlying immunosuppression and on higher levels of immunosuppression because they have more severe rheumatoid disease process. Very often it is difficult for...

Comments

at PIH Health
Why do you recommend switching IL-17 inhibitors in...

at University of Minnesota
Why IL17 inhibitors? Would you continue JAK inhibi...

at Mayo Clinic Health System
Il-17 inhibitors have been reported to have increa...

Related Questions